Literature DB >> 25818083

Severe postoperative wound healing disturbance in a patient with alpha-1-antitrypsin deficiency: the impact of augmentation therapy.

Marionna Cathomas1, Alexandra Schüller1, Daniel Candinas1, Roman Inglin1.   

Abstract

Wound healing disturbance is a common complication following surgery, but the underlying cause sometimes remains elusive. A 50-year-old Caucasian male developed an initially misunderstood severe wound healing disturbance following colon and abdominal wall surgery. An untreated alpha-1-antitrypsin (AAT) deficiency in the patient's medical history, known since 20 years and clinically apparent as a mild to moderate chronic obstructive pulmonary disease, was eventually found to be at its origin. Further clinical work-up showed AAT serum levels below 30% of the lower reference value; phenotype testing showed a ZZ phenotype and a biopsy taken from the wound area showed the characteristic, disease-related histological pattern of necrotising panniculitits. Augmentation therapy with plasma AAT was initiated and within a few weeks, rapid and adequate would healing was observed. AAT deficiency is an uncommon but clinically significant, possible cause of wound healing disturbances. An augmentation therapy ought to be considered in affected patients during the perioperative period.
© 2015 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Alpha-1-antitrypsin deficiency; Laparotomy; Panniculitis; Postoperative; Surgery; Wound healing disturbance

Mesh:

Substances:

Year:  2015        PMID: 25818083      PMCID: PMC7950604          DOI: 10.1111/iwj.12419

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  23 in total

1.  Early recognition of alpha-1 antitrypsin deficiency and considerations for liver transplantation.

Authors:  Andreas Tzakis
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-02

Review 2.  Prevalence of α1-antitrypsin deficiency alleles PI*S and PI*Z worldwide and effective screening for each of the five phenotypic classes PI*MS, PI*MZ, PI*SS, PI*SZ, and PI*ZZ: a comprehensive review.

Authors:  Frederick J de Serres; Ignacio Blanco
Journal:  Ther Adv Respir Dis       Date:  2012-08-29       Impact factor: 4.031

Review 3.  α-1-Antitrypsin deficiency: clinical variability, assessment, and treatment.

Authors:  Robert A Stockley; Alice M Turner
Journal:  Trends Mol Med       Date:  2013-12-28       Impact factor: 11.951

Review 4.  Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

Review 5.  A review of alpha-1 antitrypsin deficiency.

Authors:  Octavian C Ioachimescu; James K Stoller
Journal:  COPD       Date:  2005-06       Impact factor: 2.409

Review 6.  Alpha1-antitrypsin deficiency-associated panniculitis: case report and review of treatment options.

Authors:  P G Ortiz; B G Skov; E Benfeldt
Journal:  J Eur Acad Dermatol Venereol       Date:  2005-07       Impact factor: 6.166

Review 7.  Alpha-1-antitrypsin associated panniculitis: the MS variant.

Authors:  Pedram Geraminejad; James R DeBloom; Hobart W Walling; Richard D Sontheimer; Marta VanBeek
Journal:  J Am Acad Dermatol       Date:  2004-10       Impact factor: 11.527

Review 8.  Alpha-1-antitrypsin deficiency panniculitis.

Authors:  Ricardo Valverde; Belén Rosales; Francisco Javier Ortiz-de Frutos; José Luis Rodríguez-Peralto; Pablo L Ortiz-Romero
Journal:  Dermatol Clin       Date:  2008-10       Impact factor: 3.478

9.  Alpha 1-antitrypsin deficiency panniculitis: a histopathologic and immunopathologic study of four cases.

Authors:  W P Su; K C Smith; M R Pittelkow; R K Winkelmann
Journal:  Am J Dermatopathol       Date:  1987-12       Impact factor: 1.533

Review 10.  Update on biologic therapies in ankylosing spondylitis: a literature review.

Authors:  Leslie Goh; Ash Samanta
Journal:  Int J Rheum Dis       Date:  2012-07-09       Impact factor: 2.454

View more
  6 in total

1.  Survival after lung transplantation in recipients with alpha-1-antitrypsin deficiency compared to other forms of chronic obstructive pulmonary disease: a national cohort study.

Authors:  Brian C Gulack; Michael S Mulvihill; Asvin M Ganapathi; Paul J Speicher; Godefroy Chery; Laurie D Snyder; R Duane Davis; Matthew G Hartwig
Journal:  Transpl Int       Date:  2017-09-12       Impact factor: 3.782

2.  Alpha-1 Antitrypsin Substitution for Extrapulmonary Conditions in Alpha-1 Antitrypsin Deficient Patients.

Authors:  Boris M Baranovski; Ronen Schuster; Omer Nisim; Ido Brami; Yotam Lior; Eli C Lewis
Journal:  Chronic Obstr Pulm Dis       Date:  2018-09-19

3.  Greater survival despite increased complication rates following lung transplant for alpha-1-antitrypsin deficiency compared to chronic obstructive pulmonary disease.

Authors:  John R Spratt; Roland Z Brown; Kyle Rudser; Umesh Goswami; Marshall I Hertz; Jagadish Patil; Irena Cich; Sara J Shumway; Gabriel Loor
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

4.  A combined in silico and in vitro study on mouse Serpina1a antitrypsin-deficiency mutants.

Authors:  Reto Eggenschwiler; Atanas Patronov; Jan Hegermann; Mariane Fráguas-Eggenschwiler; Guangming Wu; Leon Cortnumme; Matthias Ochs; Iris Antes; Tobias Cantz
Journal:  Sci Rep       Date:  2019-05-16       Impact factor: 4.379

Review 5.  Fibrinolytic Serine Proteases, Therapeutic Serpins and Inflammation: Fire Dancers and Firestorms.

Authors:  Jordan R Yaron; Liqiang Zhang; Qiuyun Guo; Shelley E Haydel; Alexandra R Lucas
Journal:  Front Cardiovasc Med       Date:  2021-03-25

6.  C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency.

Authors:  Laura T Fee; Debananda Gogoi; Michael E O'Brien; Emer McHugh; Michelle Casey; Ciara Gough; Mark Murphy; Ann M Hopkins; Tomás P Carroll; Noel G McElvaney; Emer P Reeves
Journal:  Biomedicines       Date:  2021-12-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.